Fed. Circ. Affirms Invalidity Of Bayer's Yasmin Patent
In a 2-1 ruling, the U.S. Court of Appeals for the Federal Circuit found that the patent was invalid for obviousness, affirming a ruling that led Bayer to enter into a licensing agreement with Barr in mid-2008 to sell the generic product under its own label.
The patent-in-suit covers a method for...
To view the full article, register now.